First Turn Management’s Cymabay Therapeutics CBAY Stock Holding History

First Turn Management’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,497,331	Closed	-$35.4M	–	38
2023 Q4	$35.4M	Buy	+1,497,331	New	+$26.7M	5.08%	2

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

First Turn Management's CBAY Position: Q1 2024 in Review

First Turn Management sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 1,497,331 shares — an estimated $35.4M sold.

First Turn Management first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $35.4M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

First Turn Management reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
First Turn Management sold 1,497,331 Cymabay Therapeutics shares in Q1 2024, an estimated $35.4M.
First Turn Management first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
First Turn Management's Cymabay Therapeutics position peaked at $35.4M in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on First Turn Management's 13F filing for Q1 2024, filed 6 May 2024.